Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2000
04/04/2000US6045802 Antitumor agents treating cancer
04/04/2000US6045793 Recombinant ribonuclease proteins
04/04/2000US6045792 Human proteins kinases
04/04/2000US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene
04/04/2000CA2204739C Macrocyclic lactone compounds and their production process
04/04/2000CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
04/04/2000CA2078662C 4-desoxy-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
03/2000
03/30/2000WO2000017374A1 Retroviral particles protected against complement mediated destruction
03/30/2000WO2000017373A1 Recombinant celo virus and celo virus dna
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017361A2 Interferon-epsilon
03/30/2000WO2000017360A1 Cystine knot growth factor mutants
03/30/2000WO2000017358A2 Human chaperone proteins
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017328A2 Fibrils
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
03/30/2000WO2000017175A1 INHIBITORS OF p38
03/30/2000WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017159A1 Arylsulfonanilide ureas
03/30/2000WO2000017147A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity
03/30/2000WO2000017143A1 Derivatives of phenantrene for medicinal use and a process for their preparation
03/30/2000WO2000017133A2 Lta4 hydrolase inhibitors
03/30/2000WO2000016809A1 ANTISENSE MODULATION OF RhoB EXPRESSION
03/30/2000WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000WO2000016794A1 Neuroimmunophilins for selective neuronal radioprotection
03/30/2000WO2000016793A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000WO2000016781A1 Chk1 kinase inhibitors
03/30/2000WO2000016777A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
03/30/2000WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/30/2000WO2000016769A1 ACTIVE ENANTIOMER OF RARη-SPECIFIC AGONIST
03/30/2000WO2000016760A2 New use of prostaglandin e2 antagonists
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000007576A3 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE
03/30/2000WO2000002584A3 Cancer treatment methods using antibodies to aminophospholipids
03/30/2000WO2000000609A3 Molecules associated with apoptosis
03/30/2000WO2000000483A9 Tubulin binding compounds (cobra)
03/30/2000WO2000000214A3 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1999064593A3 Cell cycle regulation proteins
03/30/2000WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
03/30/2000WO1999061608A3 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
03/30/2000WO1999055831A3 Adenoviral vectors for treating disease
03/30/2000WO1999042477A3 Transporter protein for saccharide-coupled medicaments
03/30/2000DE19944695A1 Method for strengthening the antitumor activity of a crude drug containing polysaccharides comprises roasting the crude drug by far infrared rays followed by fermentation using microorganisms
03/30/2000DE19859115A1 Verwendung von Tumorzellen zeitversetzt in Kombination mit intakten Antikörpern zur Immunisierung Using time delay of tumor cells in combination with intact antibodies for immunization
03/30/2000CA2354037A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000CA2345378A1 Neuroimmunophilins for selective neuronal radioprotection
03/30/2000CA2344919A1 Active enantiomer of rar.gamma.-specific agonist
03/30/2000CA2344670A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344310A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity
03/30/2000CA2344277A1 Cystine knot growth factor mutants
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343090A1 Retroviral particles protected against complement mediated destruction
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2339866A1 Recombinant celo virus and celo virus dna
03/29/2000EP0988862A2 Formulation for use in immunisation
03/29/2000EP0988382A1 Human protein phosphatase ii-c-like protein
03/29/2000EP0988381A1 T-cell receptor beta-like protein
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988300A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988285A1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
03/29/2000EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
03/29/2000EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
03/29/2000EP0988059A2 Human quinone reductase 2 conjugates for adept and gdept
03/29/2000EP0988056A2 Tissue factor methods and compositions for coagulation and tumor treatment
03/29/2000EP0988048A1 Ligand/lytic peptide compositions and methods of use
03/29/2000EP0987943A1 A novel method of detecting and treating cancer
03/29/2000EP0778731B1 Ionene polymers containing biologically-active anions
03/29/2000EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
03/29/2000EP0739343B1 Water soluble onium salt of taxo-diterpenoid
03/29/2000EP0602123B1 Steroid sulphatase inhibitors
03/29/2000CN1249002A Component of bromelain
03/29/2000CN1248917A Method of treating prostatic diseases using active vitamin danalogues
03/29/2000CN1248916A Use of FXR, PPAR 'alpha' and LXR 'alpha' activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
03/29/2000CN1248912A Oral preparation for prophylactic and therapeutic treatment of helicobacter sp. infection
03/29/2000CN1248468A Traditional Chinese medicine Sanfeng anti-cancer capsule for curing lung cancer and preparation process thereof
03/29/2000CN1248449A Traditional Chinese medicinal preparation for treating cancer
03/29/2000CN1248442A Marine organism extract with anticancer function
03/29/2000CN1050844C Protein kinase C inhibitors
03/29/2000CN1050835C 1,5-benzodiazepine derivatives and its preparation process and use in medicine
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043365 Reacting biaryl or carbocyclic or heterocyclic isopropyl nitrile derivative with a lower alkyl ester of formic acid, condensing the intermediate formed with an aminoalkyl ester to obtain intermediate, cyclizing and condensing
1 ... 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 ... 2211